TScan Therapeutics is harnessing novel T cell systems to extend the promise of immunotherapy. TScan went public in July 2021 (NASDAQ: TCRX).
Biotech
Healthcare
AI
Details
- Founded
- 2018
- Partnered
- 2018
- Status
- Public (IPO)
- Ticker symbol
- TCRX
Investors
Related News & Research
114 Total Posts
Article
The ghost in the machine: Simulation and the future of AI-powered determination
Enterprise decision-making is scaling more accurately and efficiently with AI-simulated populations.
Article
How marketers are measuring AI search
Perfect GEO/AEO attribution doesn’t exist. The marketing leaders getting ahead are building their measurement stacks and moving anyway.
Article
What every CEO needs to know about AI governance
AI governance is now a fiduciary obligation. We break down what 'chain of custody' actually means in practice, and a seven-point action checklist you can bring to your next board meeting.